Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Mood and Appearance Satisfaction Post-COVID
NCT04439825Phase 1Completed
- Sponsor
- DeNova Research
- Start
- Jul 2020
- Primary completion
- Sep 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in mood disorder comparing Botox Arm with Placebo Arm (2 arms). Primary endpoints: Self-perception of mood at 1 month and Happiness levels at 1 month. Started Jul 2020; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
mood disorder
Beyond the preview
Go deeper on NCT04439825.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04439825.